Haizeng Y. Zhang
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China
Beijing, 100021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Tislelizumab plus bevacizumab and XELOX as first-line treatment of MSS/pMMR RAS-mutant metastatic colorectal cancer (TACTIC CRC-02): a phase II study.
Journal: ESMO open
Published: October 08, 2025
Integration of spatial and single-cell transcriptomic analysis uncovers cellular and molecular alterations in the hypertensive brain.
Journal: Life sciences
Published: August 17, 2025
Multi-omics analysis reveals different cholesterol metabolism subtypes in colorectal cancer.
Journal: Discover oncology
Published: July 15, 2025
Tumor-draining lymph nodes shape the tumor microenvironment through enrichment of tumor-reactive effector-exhausted CD8+ T cells.
Journal: Signal transduction and targeted therapy
Published: July 01, 2025
The optimal number of lymph nodes examined for rectal cancer patients undergoing neoadjuvant long-course chemoradiotherapy.
Journal: Journal of gastrointestinal oncology
Published: June 14, 2025
Immunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy.
Journal: Molecular cancer
Published: May 23, 2025
Copy number loss Of APP cause thoracic aortic dissection.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: October 19, 2024
Intestinal Gastrin/CCKBR Axis Protects against Type 2 Diabetes by Reducing Intestinal Glucose Absorption through the PI3K/Akt/eIF4B Signaling Pathway.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 21, 2024
Spatial distribution pattern of immune cells is associated with patient prognosis in colorectal cancer.
Journal: Journal of translational medicine
Published: March 10, 2024
Single-cell profiling of the copy-number heterogeneity in colorectal cancer.
Journal: Chinese medical journal
Published: March 14, 2023
Epigenetic modification of CSDE1 locus dictates immune recognition of nascent tumorigenic cells.
Journal: Science translational medicine
Published: February 01, 2023
Last Updated: 09/26/2026